Science 37 Accelerates Timelines and Expands Reach in Infectious Disease Study

An industry-leading non profit institute was looking to execute a hybrid Phase II Randomized Controlled Study to determine the effectiveness of an interventional therapy.

In this case study we show how Science 37’s unified technology platform and Direct-to-Patient Site (virtual site), helped the sponsor deliver a successful hybrid clinical trial, accelerating timeline.  Learn more about the value that this  decentralized clinical trial delivered, including:

• How partnerships played a key role in accelerated trial recruitment
• The key technology elements needed to deliver a global hybrid clinical trial
• How a virtual site model enabled seamless execution of the trial
• And more